The herpesvirus accessory protein γ134.5 facilitates viral replication by disabling mitochondrial translocation of RIG-I.
Animals
Chlorocebus aethiops
DEAD Box Protein 58
/ metabolism
Fibroblasts
/ metabolism
HEK293 Cells
Herpes Simplex
/ metabolism
Herpesvirus 1, Human
/ metabolism
Humans
Mitochondria
/ metabolism
Protein Transport
/ physiology
Receptors, Immunologic
/ metabolism
Vero Cells
Viral Proteins
/ metabolism
Virus Replication
/ physiology
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
06
08
2020
accepted:
02
03
2021
entrez:
26
3
2021
pubmed:
27
3
2021
medline:
24
7
2021
Statut:
epublish
Résumé
RIG-I and MDA5 are cytoplasmic RNA sensors that mediate cell intrinsic immunity against viral pathogens. While it has been well-established that RIG-I and MDA5 recognize RNA viruses, their interactive network with DNA viruses, including herpes simplex virus 1 (HSV-1), remains less clear. Using a combination of RNA-deep sequencing and genetic studies, we show that the γ134.5 gene product, a virus-encoded virulence factor, enables HSV growth by neutralization of RIG-I dependent restriction. When expressed in mammalian cells, HSV-1 γ134.5 targets RIG-I, which cripples cytosolic RNA sensing and subsequently suppresses antiviral gene expression. Rather than inhibition of RIG-I K63-linked ubiquitination, the γ134.5 protein precludes the assembly of RIG-I and cellular chaperone 14-3-3ε into an active complex for mitochondrial translocation. The γ134.5-mediated inhibition of RIG-I-14-3-3ε binding abrogates the access of RIG-I to mitochondrial antiviral-signaling protein (MAVS) and activation of interferon regulatory factor 3. As such, unlike wild type virus HSV-1, a recombinant HSV-1 in which γ134.5 is deleted elicits efficient cytokine induction and replicates poorly, while genetic ablation of RIG-I expression, but not of MDA5 expression, rescues viral growth. Collectively, these findings suggest that viral suppression of cytosolic RNA sensing is a key determinant in the evolutionary arms race of a large DNA virus and its host.
Identifiants
pubmed: 33770145
doi: 10.1371/journal.ppat.1009446
pii: PPATHOGENS-D-20-01727
pmc: PMC7996975
doi:
Substances chimiques
Receptors, Immunologic
0
Viral Proteins
0
RIGI protein, human
EC 3.6.1.-
DEAD Box Protein 58
EC 3.6.4.13
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1009446Subventions
Organisme : NIAID NIH HHS
ID : R37 AI087846
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI145359
Pays : United States
Organisme : NIH HHS
ID : P51 OD010425
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148148
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI146409
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127774
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI087846
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145296
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI104002
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Front Immunol. 2017 Jan 03;7:662
pubmed: 28096803
PLoS One. 2017 Aug 14;12(8):e0182961
pubmed: 28806404
J Virol. 2001 Jun;75(11):5189-96
pubmed: 11333900
Oncogene. 2008 Jul 10;27(30):4150-60
pubmed: 18362887
J Biol Chem. 2009 Jan 9;284(2):1097-105
pubmed: 19010780
Science. 1990 Nov 30;250(4985):1262-6
pubmed: 2173860
J Virol. 2018 Sep 26;92(20):
pubmed: 30045990
J Gen Virol. 1993 Nov;74 ( Pt 11):2493-7
pubmed: 8245868
J Virol. 2000 Sep;74(17):7989-96
pubmed: 10933707
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3266-70
pubmed: 1314384
J Clin Oncol. 2015 Sep 1;33(25):2780-8
pubmed: 26014293
J Virol. 2013 Jul;87(13):7301-8
pubmed: 23596298
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
PLoS Pathog. 2016 Oct 25;12(10):e1005966
pubmed: 27780231
Nature. 2007 Apr 19;446(7138):916-920
pubmed: 17392790
Clin Cancer Res. 2017 Jul 15;23(14):3566-3574
pubmed: 28495911
Immunity. 2008 Oct 17;29(4):538-50
pubmed: 18818105
Nat Immunol. 2010 Nov;11(11):997-1004
pubmed: 20890285
Genes Immun. 2015 Dec;16(8):552-66
pubmed: 26513235
J Virol. 2012 Apr;86(7):3528-40
pubmed: 22301138
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
J Virol. 2003 Mar;77(6):3409-17
pubmed: 12610116
Cell Host Microbe. 2015 Apr 8;17(4):478-88
pubmed: 25816774
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):582-7
pubmed: 17190814
J Virol. 2016 Sep 29;90(20):9406-19
pubmed: 27512060
J Virol. 2003 Oct;77(20):10917-28
pubmed: 14512542
J Virol. 2007 Nov;81(22):12128-34
pubmed: 17855538
J Virol. 2019 Nov 13;93(23):
pubmed: 31511389
PLoS Pathog. 2013;9(8):e1003533
pubmed: 23950712
J Virol. 2016 Oct 28;90(22):10414-10422
pubmed: 27630226
Trends Immunol. 2019 Dec;40(12):1134-1148
pubmed: 31735513
Annu Rev Immunol. 2018 Apr 26;36:667-694
pubmed: 29677479
Nat Immunol. 2016 May;17(5):523-30
pubmed: 26998762
J Virol. 2009 Dec;83(23):12626-30
pubmed: 19759130
J Virol. 2012 Feb;86(4):2188-96
pubmed: 22171259
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Cell Host Microbe. 2009 May 8;5(5):439-49
pubmed: 19454348
Nat Immunol. 2011 Sep 04;12(10):959-65
pubmed: 21892174
PLoS Pathog. 2018 Jan 22;14(1):e1006852
pubmed: 29357390
J Gen Virol. 1989 Nov;70 ( Pt 11):3073-8
pubmed: 2555437
Cell Host Microbe. 2019 Oct 9;26(4):493-503.e6
pubmed: 31600501
J Virol. 2013 Dec;87(24):13141-9
pubmed: 24067967
J Exp Med. 2012 Aug 27;209(9):1567-82
pubmed: 22851595
J Virol. 1990 Mar;64(3):1014-20
pubmed: 2154589
Mol Ther Oncolytics. 2017 Mar 01;5:1-10
pubmed: 28345027
Immunity. 2013 Mar 21;38(3):437-49
pubmed: 23499489
J Gen Virol. 1994 Dec;75 ( Pt 12):3679-86
pubmed: 7996163
Cell Host Microbe. 2012 May 17;11(5):528-37
pubmed: 22607805
Nat Commun. 2018 Nov 19;9(1):4841
pubmed: 30451863
J Virol. 2019 Aug 13;93(17):
pubmed: 31189704
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Lancet. 2001 May 12;357(9267):1513-8
pubmed: 11377626
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10516-20
pubmed: 7479831
Cell Host Microbe. 2007 Mar 15;1(1):23-35
pubmed: 18005679
J Virol. 2003 Jan;77(1):228-36
pubmed: 12477828
J Virol. 2014 May;88(10):5778-87
pubmed: 24623417
Science. 2013 Feb 15;339(6121):786-91
pubmed: 23258413
Nat Immunol. 2018 Jan;19(1):53-62
pubmed: 29180807
Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8
pubmed: 9023344
mBio. 2018 Jul 3;9(4):
pubmed: 29970461
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Immunol. 2004 Jul;5(7):730-7
pubmed: 15208624
J Gen Virol. 2009 Jan;90(Pt 1):74-8
pubmed: 19088275
J Virol. 2011 Oct;85(20):10899-904
pubmed: 21835791
Cell Host Microbe. 2016 Nov 9;20(5):674-681
pubmed: 27746097
PLoS Pathog. 2017 Oct 30;13(10):e1006677
pubmed: 29084250
J Biol Chem. 2014 Dec 26;289(52):35795-805
pubmed: 25355318
Cell. 2017 Sep 7;170(6):1109-1119.e10
pubmed: 28886381
Virology. 2009 Sep 1;391(2):171-6
pubmed: 19628239
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17717-22
pubmed: 16301520
J Virol. 2002 Sep;76(18):9434-45
pubmed: 12186925
EMBO J. 2006 Sep 20;25(18):4207-14
pubmed: 16946700
J Gen Virol. 1968 May;2(3):357-64
pubmed: 4300104
Nat Immunol. 2009 Oct;10(10):1065-72
pubmed: 19609254
J Virol. 2004 Jul;78(14):7653-66
pubmed: 15220440
mBio. 2017 Jul 5;8(4):
pubmed: 28679751
Nature. 2008 Oct 2;455(7213):674-8
pubmed: 18724357
J Exp Med. 2015 Aug 24;212(9):1371-9
pubmed: 26216125
PLoS Pathog. 2019 Feb 11;15(2):e1007582
pubmed: 30742689
Cell Host Microbe. 2016 Dec 14;20(6):770-784
pubmed: 27866900
Cell Host Microbe. 2010 Dec 16;8(6):496-509
pubmed: 21147464
Science. 2007 Sep 14;317(5844):1522-7
pubmed: 17872438
Cell. 2009 Aug 7;138(3):576-91
pubmed: 19631370
Nature. 2005 Oct 20;437(7062):1167-72
pubmed: 16177806
J Biochem. 2012 Jan;151(1):5-11
pubmed: 21890623
Immunotherapy. 2019 Jun;11(8):705-723
pubmed: 31045464
J Virol. 1986 Feb;57(2):629-37
pubmed: 3003394
J Virol. 2008 Jan;82(2):609-16
pubmed: 17977974
Nat Rev Immunol. 2020 Sep;20(9):537-551
pubmed: 32203325